JOSEPH LISTA: Open Payments
NPI 1134115249 · NEW CUMBERLAND, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,624 in 185 payments from 24 companies in 2025. Trend: 2023 $2,997 · 2024 $3,008 · 2025 $3,624
Food & beverage: $3,624
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 28 | $602 |
| ABBVIE INC. | 23 | $536 |
| Lilly USA, LLC | 15 | $393 |
| GlaxoSmithKline, LLC. | 23 | $273 |
| Exact Sciences Corporation | 10 | $265 |
| PFIZER INC. | 19 | $265 |
| AstraZeneca Pharmaceuticals LP | 13 | $241 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $186 |
| Amgen Inc. | 11 | $147 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $98 |
Products named: UBRELVY, Ozempic, The Cologuard Plus Collection Kit, VRAYLAR, TRELEGY ELLIPTA, JARDIANCE, Wegovy, MOUNJARO.
Industry payments across PA — which companies pay providers there.
